Endothelial cell-derived CD95 ligand serves as a chemokine in induction of neutrophil slow rolling and adhesion

Abstract
Article and author information
Metrics

Abstract

Integrin activation is crucial for regulation of leukocyte rolling, adhesion and trans-vessel migration during inflammation and occurs by engagement of myeloid cells through factors presented by inflamed vessels. However, endothelial-dependent mechanisms of myeloid cell recruitment are not fully understood. Here we show using an autoperfused flow chamber assay of whole blood neutrophils and intravital microscopy of the inflamed cremaster muscle that CD95 mediates leukocyte slow rolling, adhesion and transmigration upon binding of CD95-ligand (CD95L) that is presented by endothelial cells. In myeloid cells, CD95 triggers activation of Syk-Btk/PLCγ2/Rap1 signaling that ultimately leads to integrin activation. Excitingly, CD95-deficient myeloid cells exhibit impaired bacterial clearance in an animal model of sepsis induced by cecal ligation and puncture (CLP). Our data identify the cellular and molecular mechanisms underlying the chemoattractant effect of endothelial cell-derived CD95L in induction of neutrophil recruitment and support the use of therapeutic inhibition of CD95's activity in inflammatory diseases.

Article and author information

Author details

Liang Gao

Division of Molecular Neurobiology, German Cancer Research Center, Heidelberg, Germany

Competing interests
The authors declare that no competing interests exist.
Gülce Sila Gülcüler

Division of Molecular Neurobiology, German Cancer Research Center, Heidelberg, Germany

Competing interests
The authors declare that no competing interests exist.
Lieke Golbach

Department of Anesthesiology and Critical Care Medicine, University of Münster, Münster, Germany

Competing interests
The authors declare that no competing interests exist.
Helena Block

Department of Anesthesiology and Critical Care Medicine, University of Münster, Münster, Germany

Competing interests
The authors declare that no competing interests exist.
Alexander Zarbock

Department of Anesthesiology and Critical Care Medicine, University of Münster, Münster, Germany

Competing interests
The authors declare that no competing interests exist.
Ana Martin-Villalba

Division of Molecular Neurobiology, German Cancer Research Center, Heidelberg, Germany

For correspondence
a.martin-villalba@dkfz.de

Competing interests
The authors declare that no competing interests exist.

"This ORCID iD identifies the author of this article:" 0000-0002-9405-8910

Funding

Deutsches Krebsforschungszentrum

Ana Martin-Villalba

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experiments in this study were performed in accordance with institutional guidelines of the German Cancer Research Center and were approved by the Regierungspräsidium Karlsruhe, Germany (Permit Number G188/13).

Copyright

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.